BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11269084)

  • 21. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
    Caca-Biljanovska NG; V'lckova-Laskoska MT
    Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psoriasis treatment update].
    Guilhou JJ
    Rev Prat; 2002 Nov; 52(17):1861-3. PubMed ID: 12532861
    [No Abstract]   [Full Text] [Related]  

  • 23. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S; Rozenblit M; Lebwohl M
    J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine system as potential target for antipsoriatic therapy.
    Kemény L; Michel G; Dobozy A; Ruzicka T
    Exp Dermatol; 1994 Feb; 3(1):1-8. PubMed ID: 8061931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psoriasis in MEDLINE].
    Eveillard P
    Rev Prat; 2004 Jan; 54(1):69. PubMed ID: 15049604
    [No Abstract]   [Full Text] [Related]  

  • 26. An update on the genetics of psoriasis.
    Capon F; Trembath RC; Barker JN
    Dermatol Clin; 2004 Oct; 22(4):339-47, vii. PubMed ID: 15450331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine resolves generalized pustular psoriasis of pregnancy.
    Kapoor R; Kapoor JR
    Arch Dermatol; 2006 Oct; 142(10):1373-5. PubMed ID: 17043209
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3.
    Holm SJ; Sánchez F; Carlén LM; Mallbris L; Ståhle M; O'Brien KP
    Acta Derm Venereol; 2005; 85(1):2-8. PubMed ID: 15848982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporin in psoriasis: how?
    Feldman SR; Garton R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):250-3. PubMed ID: 15096128
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatments for chronic palmoplantar pustular psoriasis.
    Marsland AM; Griffiths CE
    Skin Therapy Lett; 2001 Nov; 6(12):3-5. PubMed ID: 11753536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis--recent advances in understanding its pathogenesis and treatment.
    Krueger G; Ellis CN
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S94-100. PubMed ID: 15968269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of action of topical therapies and the rationale for combination therapy.
    Norris DA
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients.
    Adişen E; Tekin O; Gülekon A; Gürer MA
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):814-9. PubMed ID: 19470063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human leukocyte antigens as psoriasis inheritance and susceptibility markers.
    Szczerkowska-Dobosz A
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):428-33. PubMed ID: 16314826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5.
    Vasilopoulos Y; Walters K; Cork MJ; Duff GW; Sagoo GS; Tazi-Ahnini R
    Eur J Hum Genet; 2008 Aug; 16(8):1002-9. PubMed ID: 18364739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of HLA-Cw*06 allele frequency with some clinical features of psoriasis vulgaris in the population of northern Poland.
    Szczerkowska-Dobosz A; Rebała K; Szczerkowska Z; Witkowska-Toboła A
    J Appl Genet; 2004; 45(4):473-6. PubMed ID: 15523160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current thinking on psoriasis.
    Donaldson L; Douglas WS
    Practitioner; 1997 Feb; 241(1571):66-8, 70, 72. PubMed ID: 9156493
    [No Abstract]   [Full Text] [Related]  

  • 38. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis: mechanisms and entry points for possible therapeutic interventions.
    Christophers E
    Australas J Dermatol; 1996 May; 37 Suppl 1():S4-6. PubMed ID: 8713012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psoriasis: the treatment and prevention of recurrences].
    Skripkin IuK; Chistiakova IA
    Ter Arkh; 1993; 65(10):67-71. PubMed ID: 8296239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.